... for a 2.70 credit.
Comments: 30-day IV remains fairly decent here at 48.9%. Going wider than I usually do from a delta standpoint, with the short option legs camped out at the 16 delta, but with the wings at standard width (1/10th the price of the underlying), knowing that I will probably adjust the setup at some point given its duration (56 DTE).
Earnings haven't been firmly announced yet, but are likely to occur right around mopex (~11/14), so will look to be out of the trade by then.
Metrics:
Buying Power Effect: 12.30
Max Profit: 2.70
ROC at Max: 21.95%
50% Max: 1.35
ROC at 50% Max: 10.98%
Will generally look to take profit at 50% max; roll in sides to delta balance.
Comments: 30-day IV remains fairly decent here at 48.9%. Going wider than I usually do from a delta standpoint, with the short option legs camped out at the 16 delta, but with the wings at standard width (1/10th the price of the underlying), knowing that I will probably adjust the setup at some point given its duration (56 DTE).
Earnings haven't been firmly announced yet, but are likely to occur right around mopex (~11/14), so will look to be out of the trade by then.
Metrics:
Buying Power Effect: 12.30
Max Profit: 2.70
ROC at Max: 21.95%
50% Max: 1.35
ROC at 50% Max: 10.98%
Will generally look to take profit at 50% max; roll in sides to delta balance.
Trade attivo
Closed just the in-profit short strangle body for a 3.15 debit and reset with a 16 delta short strangle at the 107/146 for a 3.73 credit.Total credits collected of 3.31.
Trade attivo
Rolled the 83/107 short put vertical up to the 92/116 (short leg at the 16 delta) for an .87 credit. 4.18 net credits collected with the resulting setup being the Nov 15th 92/116/146/158 iron condor.Trade chiuso manualmente
Closed for a 3.75 debit; .43 ($43) winner.
Declinazione di responsabilità
Le informazioni e le pubblicazioni non sono intese come, e non costituiscono, consulenza o raccomandazioni finanziarie, di investimento, di trading o di altro tipo fornite o approvate da TradingView. Per ulteriori informazioni, consultare i Termini di utilizzo.
Declinazione di responsabilità
Le informazioni e le pubblicazioni non sono intese come, e non costituiscono, consulenza o raccomandazioni finanziarie, di investimento, di trading o di altro tipo fornite o approvate da TradingView. Per ulteriori informazioni, consultare i Termini di utilizzo.